An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding

PLoS Medicine

Volumn 6, Issue 6, 2009, Pages

  Chiasson, T Carter ^a   Manns, Braden J ^a   Stelfox, Henry Thomas ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INJURY; ADULT; ARTICLE; BLEEDING; COMPRESSION THERAPY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; ECONOMIC EVALUATION; EMERGENCY HEALTH SERVICE; FACE INJURY; FEMALE; HEAD AND NECK INJURY; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INJURY SCALE; INTENSIVE CARE UNIT; LIMB INJURY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PELVIS INJURY; QUALITY OF LIFE; SCREENING; THORAX INJURY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MALE; MARKOV CHAINS; PULMONARY EMBOLISM; ULTRASONOGRAPHY, DOPPLER; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 67650224455     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000098     Document Type: Article

References (43)

1. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA (2002) Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma 53: 142-164.
2. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331: 1601-1606.
3. Kelly J, Hunt BJ (2003) Do anticoagulants improve survival in patients presenting with venous thromboembolism? J Intern Med 254: 527-539.
4. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, et al. (1992) The clinical course of pulmonary embolism. N Engl J Med 326: 1240-1245.
5. Geerts WH (2006) Prevention of venous thromboembolism in high-risk patients. Hematology Am Soc Hematol Educ Program. pp 462-466.
6. Karmy-Jones R, Jurkovich GJ, Velmahos GC, Burdick T, Spaniolas K, et al. (2007) Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J Trauma 62: 17-24.
7. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338: 409-415.
8. Wojcik R, Cipolle MD, Fearen I, Jaffe J, Newcomb J, et al. (2000) Long-term follow-up of trauma patients with a vena caval filter. J Trauma 49: 839-843.
9. Botteman MF, Caprini J, Stephens JM, Nadipelli V, Bell CF, et al. (2002) Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther 24: 1960-1986.
10. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, et al. (1997) The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 82: 423-428.
11. Shackford SR, Cook A, Rogers FB, Littenberg B, Osler T (2007) The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank. J Trauma 63: 764-769.
12. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, et al. (2001) Prevention of venous thromboembolism. Chest 119: 132S-175S.
13. Girard P, Stern JB, Parent F (2002) Medical literature and vena cava filters: so far so weak. Chest 122: 963-967.
14. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, et al. (2007) Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma 24(Suppl 1): S32-36.
15. Baker SP, O'Neill B, Haddon W Jr, Long WB (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14: 187-196.
16. Naimark D, Krahn MD, Naglie G, Redelmeier DA, Detsky AS (1997) Primer on medical decision analysis: Part 5-Working with Markov processes. Med Decis Making 17: 152-159.
17. Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, et al. (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335: 701-707.
18. Napolitano LM, Garlapati VS, Heard SO, Silva WE, Cutler BS, et al. (1995) Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma 39: 651-657.
19. Alpert JS, Dalen JE (1994) Epidemiology and natural history of venous thromboembolism. Prog Cardiovasc Dis 36: 417-422.
20. O'Brien BJ, Anderson DR, Goeree R (1994) Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. CMAJ 150: 1083-1090.
21. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM (1999) Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 130: 800-809.
22. Becker DM, Philbrick JT, Selby JB (1992) Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 152: 1985-1994.
23. Korosec Jagodic H, Jagodic K, Podbregar M (2006) Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma. Crit Care 10: R134.
24. Jones J, Hunter D (1995) Consensus methods for medical and health services research. BMJ 311: 376-380.
25. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA (2000) Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med 28: 3599-3605.
26. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C (2002) An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 347: 993-1000.
27. Aujesky D, Smith KJ, Cornuz J, Roberts MS (2005) Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. Chest 128: 1601-1610.
28. Rogers FB, Strindberg G, Shackford SR, Osler TM, Morris CS, et al. (1998) Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg 133: 406-411.
29. Brasel KJ, Borgstrom DC, Weigelt JA (1997) Cost-effective prevention of pulmonary embolus in high-risk trauma patients. J Trauma 42: 456-460.
30. Imberti D, Ageno W (2005) A survey of thromboprophylaxis management in patients with major trauma. Pathophysiol Haemost Thromb 34: 249-254.
31. Maxwell RA, Chavarria-Aguilar M, Cockerham WT, Lewis PL, Barker DE, et al. (2002) Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma 52: 902-906.
32. Cherry RA, Nichols PA, Snavely TM, David MT, Lynch FC (2008) Prophylactic inferior vena cava filters: do they make a difference in trauma patients? J Trauma 65: 544-548.
33. Antevil JL, Sise MJ, Sack DI, Sasadeusz KJ, Swanson SM, et al. (2006) Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale. J Trauma 60: 35-40.
34. McMurtry AL, Owings JT, Anderson JT, Battistella FD, Gosselin R (1999) Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. J Am Coll Surg 189: 314-320.
35. O'Brien B (1996) Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? Med Care 34: DS99-108.
36. Champion HR, Copes WS, Sacco WJ, Lawnick MM, Keast SL, et al. (1990) The Major Trauma Outcome Study: establishing national norms for trauma care. J Trauma 30: 1356-1365.
37. Osler T, Glance L, Buzas JS, Mukamel D, Wagner J, et al. (2008) A trauma mortality prediction model based on the anatomic injury scale. Ann Surg 247: 1041-1048.
38. Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, et al. (2008) Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 5: e165; discussion e165.
39. (2006) Guidelines for the Economic Evaluation of Health Technologies: Canada. 3rd Edition ed: Canadian Agency for Drugs and Technologies in Health.
40. Manns BJ, Mortis GP, Taub KJ, McLaughlin K, Donaldson C, et al. (2001) The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med 24: 164-170.
41. Government A (2007) Drug Benefit List and Suppliment.
42. Lee H, Doig CJ, Ghali WA, Donaldson C, Johnson D, et al. (2004) Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med 32: 981-985.
43. Alberta Medical Association (2007) Fees & Billings. Alberta Medical Association.